Zevra Therapeutics (ZVRA) Asset Utilization Ratio (2019 - 2026)

Zevra Therapeutics has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.43 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 88.06% year-over-year to 0.43; the trailing twelve-month figure through Mar 2026 stood at 0.43 (up 88.06% YoY), and the FY2025 full-year result was 0.46, up 241.41% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.43, up from 0.38 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.43 in Q1 2026, with the low at 0.07 in Q2 2022.
• Historically, Asset Utilization Ratio has averaged 0.19 across 5 years, with a median of 0.16 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 72.26% — and 2025, when it jumped 201.9%.
• Zevra Therapeutics' Asset Utilization Ratio stood at 0.08 in 2022, then jumped by 128.19% to 0.18 in 2023, then dropped by 27.91% to 0.13 in 2024, then jumped by 201.9% to 0.38 in 2025, then increased by 13.11% to 0.43 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.43 (Q1 2026), 0.38 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.